Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 35% ± 19% | |
peripheral blood | 12 studies | 30% ± 12% | |
intestine | 11 studies | 28% ± 12% | |
brain | 11 studies | 35% ± 18% | |
eye | 9 studies | 31% ± 9% | |
kidney | 6 studies | 28% ± 8% | |
uterus | 5 studies | 48% ± 18% | |
liver | 5 studies | 34% ± 18% | |
pancreas | 4 studies | 50% ± 16% | |
bone marrow | 4 studies | 23% ± 5% | |
heart | 4 studies | 22% ± 5% | |
lymph node | 4 studies | 24% ± 7% | |
breast | 4 studies | 30% ± 6% | |
placenta | 3 studies | 28% ± 7% | |
prostate | 3 studies | 34% ± 6% | |
adipose | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 29549.48 | 1445 / 1445 | 100% | 159.80 | 183 / 183 |
ovary | 100% | 15450.82 | 180 / 180 | 100% | 163.65 | 430 / 430 |
uterus | 100% | 21367.72 | 170 / 170 | 100% | 205.48 | 459 / 459 |
breast | 100% | 11851.72 | 459 / 459 | 100% | 163.89 | 1114 / 1118 |
bladder | 100% | 20362.14 | 21 / 21 | 100% | 142.31 | 502 / 504 |
prostate | 100% | 17717.54 | 244 / 245 | 100% | 265.19 | 502 / 502 |
lung | 99% | 14167.16 | 574 / 578 | 100% | 177.52 | 1155 / 1155 |
thymus | 99% | 9046.98 | 649 / 653 | 100% | 150.38 | 603 / 605 |
brain | 98% | 8841.64 | 2593 / 2642 | 100% | 179.31 | 705 / 705 |
intestine | 100% | 16409.96 | 965 / 966 | 98% | 107.46 | 517 / 527 |
adrenal gland | 100% | 8901.28 | 258 / 258 | 98% | 89.09 | 225 / 230 |
stomach | 99% | 11748.67 | 356 / 359 | 99% | 101.32 | 282 / 286 |
kidney | 98% | 7831.38 | 87 / 89 | 99% | 124.31 | 896 / 901 |
skin | 100% | 10525.84 | 1805 / 1809 | 92% | 90.64 | 432 / 472 |
pancreas | 82% | 4210.03 | 268 / 328 | 99% | 136.95 | 176 / 178 |
liver | 68% | 2964.53 | 154 / 226 | 92% | 55.26 | 374 / 406 |
blood vessel | 100% | 34685.85 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 72.59 | 29 / 29 |
muscle | 100% | 24929.10 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8310.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 150.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 57.20 | 1 / 1 |
adipose | 100% | 12036.09 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 12207.01 | 816 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 6653.20 | 750 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 59.23 | 64 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0000165 | Biological process | MAPK cascade |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0051301 | Biological process | cell division |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0005730 | Cellular component | nucleolus |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0072357 | Cellular component | PTW/PP1 phosphatase complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0050115 | Molecular function | myosin-light-chain-phosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP1CB |
Protein name | protein-serine/threonine phosphatase (EC 3.1.3.16) Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53) Protein phosphatase 1 catalytic subunit beta Serine/threonine-protein phosphatase (EC 3.1.3.16) |
Synonyms | |
Description | FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective . . |
Accessions | ENST00000395366.3 C9J9S3 C9JP48 ENST00000703171.1 ENST00000420282.5 ENST00000441461.6 B4DJ75 ENST00000703176.1 A0A8V8TQ71 ENST00000703172.1 ENST00000703174.1 F8WE71 P62140 H0Y3Y6 A0A8V8TR83 ENST00000427786.2 ENST00000455580.6 ENST00000418910.2 ENST00000703177.1 ENST00000703173.1 ENST00000420282.6 A0A8V8TRH9 ENST00000441461.5 ENST00000296122.10 |